These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13166538)

  • 21. A serological investigation of six encephalitis viruses isolated in Malaya.
    HALE JH; LEE LH
    Br J Exp Pathol; 1954 Oct; 35(5):426-33. PubMed ID: 13208931
    [No Abstract]   [Full Text] [Related]  

  • 22. A serological survey of antibodies to Japanese B encephalitis virus among horses in Malaya.
    HALE JH; WITHERINGTON DH
    Ann Trop Med Parasitol; 1954 Mar; 48(1):15-20. PubMed ID: 13149114
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolation of Japanese B encephalitis virus; report of a fatal case in an American soldier returned from Korea.
    BERGE TO; SHUEY HE
    J Am Med Assoc; 1956 Oct; 162(6):564-7. PubMed ID: 13366638
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antiviral effect of an extract of Luffa cylindrica (L 043) on Japanese B encephalitis virus infection in vivo].
    Xu ZX; Li LQ; Zhou ZQ; Qu FZ; Tong LL
    Wei Sheng Wu Xue Bao; 1985 Mar; 25(1):66-8. PubMed ID: 3006360
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental stillbirth in pregnant swine infected with Japanese encephalitis virus.
    SHIMIZU T; KAWAKAMI Y; FUKUHARA S; MATUMOTO M
    Jpn J Exp Med; 1954 Dec; 24(6):363-75. PubMed ID: 13270968
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor suppressor p53 functions as an essential antiviral molecule against Japanese encephalitis virus.
    Deng X; Wei J; Shi Z; Yan W; Wu Z; Shao D; Li B; Liu K; Wang X; Qiu Y; Ma Z
    J Genet Genomics; 2016 Dec; 43(12):709-712. PubMed ID: 27956051
    [No Abstract]   [Full Text] [Related]  

  • 27. HETEROGENEITY IN THE HEMAGGLUTINATING AGENT OF JAPANESE B ENCEPHALITIS VIRUS.
    IGARASHI A; KITANO H; FUKAI K
    Biken J; 1963 Apr; 6():25-6. PubMed ID: 14050732
    [No Abstract]   [Full Text] [Related]  

  • 28. Japanese B encephalitis virus in tissue culture.
    MCCOLLUM RW; FOLEY JF
    Proc Soc Exp Biol Med; 1957 Mar; 94(3):556-60. PubMed ID: 13408325
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies of the antiviral activity of 4-acetylamino-naphthalene-lauroyl-sulfonamide-1 (PANS).
    WEINSTEIN L; CHANG TW
    Antibiot Chemother (Northfield); 1960 Apr; 10():214-20. PubMed ID: 13843625
    [No Abstract]   [Full Text] [Related]  

  • 30. [JAPANESE B ENCEPHALITIS VIRUS. 10. COMPARISON OF ALCOHOL-PROTAMINE TREATED AND STREPTOMYCIN-TREATED VIRUSES].
    YOSHIKAWA S
    Igaku To Seibutsugaku; 1965 Feb; 70():77-81. PubMed ID: 14287355
    [No Abstract]   [Full Text] [Related]  

  • 31. A study on the haemagglutinin of the Nakayama strain of Japanese B encephalitis virus.
    AUSTIN FJ
    Aust J Exp Biol Med Sci; 1954 Dec; 32(6):885-92. PubMed ID: 14363062
    [No Abstract]   [Full Text] [Related]  

  • 32. Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection.
    Wang S; Liu Y; Guo J; Wang P; Zhang L; Xiao G; Wang W
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges.
    Ishikawa T; Konishi E
    Expert Opin Ther Targets; 2015; 19(10):1379-95. PubMed ID: 26156208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Researches on chemotherapeutic drugs against viruses. XXXV. Syntheses and antiviral activity of alkylated ephedrine and its related compounds.
    FURUKAWA M; TOYOSHIMA S
    Chem Pharm Bull (Tokyo); 1963 Apr; 11():518-23. PubMed ID: 13945907
    [No Abstract]   [Full Text] [Related]  

  • 35. [Possibilities of obtaining hyperimmune guinea pig serums with the St. Louis and Japanese B encephalitis viruses].
    GALLARDO MARTINEZ E; GARCIA GANCEDO AP
    Microbiol Esp; 1956; 9(1):1-27. PubMed ID: 13348090
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses.
    Chen L; Liu Y; Wang S; Sun J; Wang P; Xin Q; Zhang L; Xiao G; Wang W
    Antiviral Res; 2017 May; 141():140-149. PubMed ID: 28232248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [JAPANESE B ENCEPHALITIS VIRUS. 7. A SIMPLIFIED MICRO-TITRATION METHOD FOR RESIDUAL COMPLEMENT].
    YOSHIKAWA S
    Igaku To Seibutsugaku; 1965 Jan; 70():32-6. PubMed ID: 14294537
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent developments in vaccines and biological therapies against Japanese encephalitis virus.
    Barzon L; Palù G
    Expert Opin Biol Ther; 2018 Aug; 18(8):851-864. PubMed ID: 29991325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hamster kidney cell tissue cultures for propagation of Japanese B encephalitis virus.
    DIERCKS FH; HAMMON WM
    Proc Soc Exp Biol Med; 1958 Mar; 97(3):627-32. PubMed ID: 13518356
    [No Abstract]   [Full Text] [Related]  

  • 40. [JAPANESE B ENCEPHALITIS VIRUS. 9. PRESSURIZED DENSITY GRADIENT ELUTION ON HYDROXYL APATITE COLUMN].
    YOSHIKAWA S
    Igaku To Seibutsugaku; 1965 Feb; 70():63-6. PubMed ID: 14287351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.